Synfini will dramatically reduce the time and cost of modern molecular discovery...

By uniting physical and virtual chemistry through expert-curated AI and discovery-focused robotic automation, leading to the most dynamic synthesis data and designer molecules.

A suite of hardware solutions, combined with cutting-edge AI technologies, holds great promise for accelerating the speed at which biopharma companies can develop new therapeutics — and for creating a healthier future for all

Synfini will:

  • Dramatically accelerate drug discovery
  • Help drug hunters looking for superior, faster, lower-cost exploration of chemical space
  • Discover optimized molecules and the ability to easily pivot based on evolving biology and personalized medicine requirements
  • Improve drug licensing value
  • Help pharma companies that are under regulatory pressure, and to find cost efficiencies and address previously underserved ‘niche’ markets more effectively.